Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 13, 2026

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

Reply: To PMID 22495332

Peizeng Yang, Ni Zhang, Aize Kijlstra

    Retina (Philadelphia, Pa.)
    |March 7, 2013
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Last Updated: May 13, 2026

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
    10:33

    Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

    Published on: December 17, 2021

    Related Concept Videos

    Chi-square Analysis02:46

    Chi-square Analysis

    The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
    The chi-square test was developed by Pearson in 1990.
    The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease.

    Journal of autoimmunity·2023
    Same author

    NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway.

    Arthritis & rheumatology (Hoboken, N.J.)·2022
    Same author

    Epitope vaccine design for Toxoplasma gondii based on a genome-wide database of membrane proteins.

    Parasites & vectors·2022
    Same author

    Ploidy Identification by Flow Cytometry and Application of the Method to Characterize Seasonal Ploidy Variation of Wild Populations of the Red Alga Gracilariopsis lemaneiformis.

    Marine biotechnology (New York, N.Y.)·2022
    Same author

    Generation of a human induced pluripotent stem cell line (LZUSHi002-A) from a MADD patient with ETFDH mutation.

    Stem cell research·2022
    Same author

    Apatinib and temozolomide in children with recurrent ependymoma: A case report.

    Medicine·2022
    Same journal

    Persistent placoid maculopathy: long term outcomes and prognostic factors.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    ANTI-VEGF THERAPY SWITCHING RETINAL DISEASES: Characterizing Clinical Manifestations and Common Involved Genes: ERRATUM.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    THE EFFICACY AND SAFETY OF SUBRETINAL BALANCED SALT SOLUTION INJECTION IN DIABETIC MACULAR EDEMA WITH HARD EXUDATES: ERRATUM.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    EVALUATING CLINICAL OUTCOMES OF AMNIOTIC MEMBRANE COVERAGE COMBINED WITH EARLY VITRECTOMY IN THE MANAGEMENT OF PERFORATING GLOBE INJURIES.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    Mid-Phase Hyperfluorescent Plaques as a biomarker of disease activity in Central Serous Chorioretinopathy: Clinical Course and Treatment Response - MICRoN report number Ten.

    Retina (Philadelphia, Pa.)·2026
    Same journal

    Severe retinal non-perfusion is associated with fewer retinal lesions on ultra-wide field fundus photography in proliferative diabetic retinopathy.

    Retina (Philadelphia, Pa.)·2026
    See all related articles